These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 28542740

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Circulating microRNAs as predictive biomarkers of myocardial infarction: Evidence from the HUNT study.
    Velle-Forbord T, Eidlaug M, Debik J, Sæther JC, Follestad T, Nauman J, Gigante B, Røsjø H, Omland T, Langaas M, Bye A.
    Atherosclerosis; 2019 Oct; 289():1-7. PubMed ID: 31437610
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G.
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [Abstract] [Full Text] [Related]

  • 70. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
    Dong X, Chang M, Song X, Ding S, Xie L, Song X.
    Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
    [Abstract] [Full Text] [Related]

  • 71. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
    Trakunram K, Chaniad P, Geater SL, Keeratichananont W, Chittithavorn V, Uttayamakul S, Buya S, Raungrut P, Thongsuksai P.
    Cancer Biol Med; 2020 Aug 15; 17(3):652-663. PubMed ID: 32944397
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y, Abou Tayoun AN, Abo KM, Pipas JM, Gordon SR, Gardner TB, Barth RJ, Suriawinata AA, Tsongalis GJ.
    Cancer Genet; 2013 Jun 15; 206(6):217-21. PubMed ID: 23933230
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Tumor-Specific miRNA Signatures in Combination with CA19-9 for Liquid Biopsy-Based Detection of PDAC.
    Kim MW, Koh H, Kim JY, Lee S, Lee H, Kim Y, Hwang HK, Kim SI.
    Int J Mol Sci; 2021 Dec 19; 22(24):. PubMed ID: 34948417
    [Abstract] [Full Text] [Related]

  • 79. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
    Yu S, Li Y, Liao Z, Wang Z, Wang Z, Li Y, Qian L, Zhao J, Zong H, Kang B, Zou WB, Chen K, He X, Meng Z, Chen Z, Huang S, Wang P.
    Gut; 2020 Mar 19; 69(3):540-550. PubMed ID: 31562239
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.